Skip to main content

Animations

MJFF Publications

6831 - 6840 of 9038 Results
Title
Year
  • Year
  • 2023
  • 2025
  • 2025
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • Summary Details
    OPEN
    Title: Unique functional responses differentially map onto genetic subtypes of dopamine neurons
    Journal Name: Nature Neuroscience
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41593-023-01401-9
    Citation Count: 165
  • Summary Details
    OPEN
    Title: Biobank-scale genetic characterization of Alzheimer’s disease and related dementias across diverse ancestries
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-025-62108-y
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Disruption of the cerebrospinal fluid–plasma protein balance in cognitive impairment and aging
    Journal Name: Nature Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1038/s41591-025-03831-3
    Citation Count: 23
  • Summary Details
    OPEN
    Title: Cell-free RNA signatures predict Alzheimer’s disease
    Journal Name: iScience
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.isci.2023.108534
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Validating virtual administration of neuropsychological testing in Parkinson disease: a pilot study
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-023-42934-0
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Genome-wide screen reveals Rab12 GTPase as a critical activator of Parkinson’s disease-linked LRRK2 kinase
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.7554/elife.87098
    Citation Count: 74
  • Summary Details
    OPEN
    Title: In vitro modeling of the human dopaminergic system using spatially arranged ventral midbrain–striatum–cortex assembloids
    Journal Name: Nature Methods
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41592-023-02080-x
    Citation Count: 100
  • Summary Details
    OPEN
    Title: hipFG: high-throughput harmonization and integration pipeline for functional genomics data
    Journal Name: Bioinformatics
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/bioinformatics/btad673
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Scaling of an antibody validation procedure enables quantification of antibody performance in major research applications
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.7554/elife.91645
    Citation Count: 63
  • Summary Details
    OPEN
    Title: In Silico and In Vitro Study towards the Rational Design of 4,4′-Disarylbisthiazoles as a Selective α-Synucleinopathy Biomarker
    Journal Name: International Journal of Molecular Sciences
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/ijms242216445
    Citation Count: 5
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.